GO:1904380 endoplasmic reticulum mannose trimming: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904380 describes protein alpha-1,2-demannosylation occurring in the endoplasmic reticulum quality control compartment (ERQC).
• Mannose trimming generates Man6-5GlcNAc2 intermediates that act as a dominant signal for releasing misfolded glycoproteins from ER quality control.
• EDEM1, EDEM2, EDEM3 and ER mannosidase I catalyze sequential mannose removal and channel substrates to ER-associated degradation (ERAD).
• Mannose trimming is required for delivery of glycoproteins from EDEM1 to XTP3-B and for progression to late ERAD steps.
• UGGT1-mediated reglucosylation competes with mannose trimming and ERAD, creating a folding-versus-degradation checkpoint.
• Dysregulated mannose trimming contributes to cancer progression, as shown for COPB2-facilitated EDEM3 activity in ovarian cancer.
Description
Endoplasmic reticulum mannose trimming (GO:1904380) is the biological process defined as any protein alpha-1,2-demannosylation that takes place in the endoplasmic reticulum quality control compartment (ERQC). This process is a central step in glycoprotein quality control, where N-linked glycans on newly synthesized proteins are progressively trimmed to generate specific mannose isomers that serve as timers and signals for protein folding, retention, or degradation. Researchers study GO:1904380 because it determines the fate of secretory and membrane proteins: correctly folded proteins exit the ER, whereas terminally misfolded species are targeted for ER-associated degradation (ERAD). The trimming reaction is not merely a metabolic step but a decisive signaling event, as mannose trimming is the dominant signal for the release of misfolded glycoproteins from ER quality control. Consequently, the enzymes and lectins that execute and interpret mannose trimming are implicated in diseases ranging from cancer to protein conformational disorders.
endoplasmic reticulum mannose trimming At A Glance
| GO ID | GO:1904380 |
|---|---|
| GO term | endoplasmic reticulum mannose trimming |
| Ontology | biological_process |
| Synonym | ER mannose trimming; ER protein alpha-1,2-demannosylation; glycoprotein mannose trimming in ERQC; protein alpha-1,2-demannosylation in ER quality control compartment |
| Major function | Removal of alpha-1,2-mannose residues from N-glycans in the ERQC to generate degradation signals and regulate glycoprotein fate |
| Subcellular location | Endoplasmic reticulum quality control compartment (ERQC) |
| Key enzymes | ER mannosidase I, EDEM1, EDEM2, EDEM3 |
| Key lectins | XTP3-B, OS-9, EDEM1 |
| Competing activity | UGGT1-mediated reglucosylation |
What Is GO:1904380?
GO:1904380 refers to any protein alpha-1,2-demannosylation that occurs within the endoplasmic reticulum quality control compartment (ERQC). In practice, this means the enzymatic removal of alpha-1,2-linked mannose residues from N-glycans of glycoproteins while they are still in the ERQC, producing trimmed oligosaccharides such as Man6-5GlcNAc2 that are recognized by lectin adaptors and direct substrates toward ER-associated degradation.
Why Is endoplasmic reticulum mannose trimming Important in Cell Biology?
Mannose trimming is important because it converts N-glycan structures into a biochemical timer that determines whether a glycoprotein is retained for further folding or delivered to ERAD. This decision protects the cell from accumulation of misfolded proteins, and its dysregulation is linked to cancer and other diseases. The process also defines the substrate specificity of ERAD lectins and the kinetics of glycoprotein secretion, making it a key node for experimental manipulation in cell biology and biotechnology.
• Generates Man6-5GlcNAc2 intermediates that signal misfolded glycoproteins for ERAD.
• Acts as the dominant release signal for misfolded glycoproteins from ER quality control.
• Required for delivery of glycoproteins from EDEM1 to XTP3-B and late ERAD steps.
• Competes with UGGT1-mediated reglucosylation, setting the folding-versus-degradation balance.
• ER mannosidase I is compartmentalized and required for N-glycan trimming to Man5-6GlcNAc2 in glycoprotein ERAD.
• EDEM3 enhances glycoprotein ERAD and mannose trimming.
• COPB2 facilitates EDEM3-mediated mannose trimming to sustain ER homeostasis in ovarian cancer.
• Dysregulation can contribute to cancer progression and ER stress-related pathology.
• Provides targets for modulating secretion and stability of therapeutic glycoproteins.
• Serves as a model for studying glycan code interpretation in the secretory pathway.
What Happens During endoplasmic reticulum mannose trimming?
Initial N-glycan processing and ER mannosidase I activity
In simple terms: The sugar tree on a new protein is trimmed step by step, starting with removal of specific mannose residues by ER mannosidase I.
After cotranslational N-glycosylation, the N-glycan is progressively trimmed. ER mannosidase I is compartmentalized and required for N-glycan trimming to Man5-6GlcNAc2 in glycoprotein ERAD. This initial alpha-1,2-demannosylation in the ERQC generates the Man6-5GlcNAc2 intermediates that are characteristic of GO:1904380.
EDEM-mediated acceleration and generation of degradation signals
In simple terms: EDEM proteins speed up mannose trimming to create a tag that tells the cell the protein is misfolded.
EDEM3, a soluble EDEM homolog, enhances glycoprotein ERAD and mannose trimming. Mannose trimming is the dominant signal for the release of misfolded glycoproteins from ER quality control. Thus, EDEM family members accelerate the trimming reaction to produce Man6-5GlcNAc2 structures that act as degradation signals.
Lectin recognition and substrate delivery to ERAD
In simple terms: Trimmed sugars are recognized by lectin proteins that hand the misfolded protein over to the degradation machinery.
Mannose trimming is required for delivery of a glycoprotein from EDEM1 to XTP3-B and to late ERAD steps. This step links the glycan code generated by GO:1904380 to the downstream ERAD lectin network, including XTP3-B and OS-9.
Competition with reglucosylation and the folding checkpoint
In simple terms: Another enzyme can add glucose back to the sugar, competing with trimming and giving the protein more chances to fold.
UGGT1-mediated reglucosylation of N-glycan competes with ER-associated degradation of unstable and misfolded glycoproteins. This competition between reglucosylation and mannose trimming creates a kinetic checkpoint that determines whether a glycoprotein is retained for folding or committed to ERAD.
Key Genes Involved in GO:1904380 endoplasmic reticulum mannose trimming
The following genes and proteins are central to endoplasmic reticulum mannose trimming (GO:1904380) and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAN1B1 | ER mannosidase I; catalyzes initial alpha-1,2-demannosylation in ERQC | Required for N-glycan trimming to Man5-6GlcNAc2 in glycoprotein ERAD |
| EDEM1 | ER degradation-enhancing alpha-mannosidase-like protein 1; accelerates mannose trimming and substrate delivery | Required for delivery of glycoproteins to XTP3-B and late ERAD steps |
| EDEM2 | EDEM homolog; contributes to mannose trimming and ERAD | Part of the EDEM family that enhances glycoprotein ERAD |
| EDEM3 | Soluble EDEM homolog; enhances glycoprotein ERAD and mannose trimming | Directly implicated in mannose trimming and ERAD enhancement |
| XTP3-B | ER lectin that recognizes trimmed glycans | Receives substrates from EDEM1 during late ERAD steps |
| OS-9 | ER lectin involved in ERAD substrate recognition | Part of the lectin network interpreting mannose-trimmed glycans |
| UGGT1 | UDP-glucose:glycoprotein glucosyltransferase 1; reglucosylates N-glycans | Competes with mannose trimming and ERAD |
| COPB2 | Coatomer subunit; facilitates EDEM3-mediated mannose trimming | Sustains ER homeostasis in ovarian cancer |
| MAN1A1 | Alpha-1,2-mannosidase involved in N-glycan processing | Contributes to alpha-1,2-demannosylation in the secretory pathway |
| MAN1A2 | Alpha-1,2-mannosidase involved in N-glycan processing | Contributes to alpha-1,2-demannosylation in the secretory pathway |
| MAN1C1 | Alpha-1,2-mannosidase involved in N-glycan processing | Contributes to alpha-1,2-demannosylation in the secretory pathway |
| DERL1 | Derlin-1; ERAD retrotranslocation component | Downstream of mannose trimming in ERAD |
| DERL2 | Derlin-2; ERAD retrotranslocation component | Downstream of mannose trimming in ERAD |
| SEL1L | ERAD adaptor protein | Links glycan trimming to ERAD machinery |
| HRD1 | E3 ubiquitin ligase in ERAD | Downstream of mannose trimming in ERAD |
| UBE2J1 | ER-associated ubiquitin-conjugating enzyme | Participates in ERAD downstream of mannose trimming |
| VCP | Valosin-containing protein; extracts ERAD substrates | Late ERAD step after mannose trimming |
| BAG6 | Chaperone involved in ERAD | Contributes to degradation of mannose-trimmed substrates |
How Is endoplasmic reticulum mannose trimming Regulated?
Mannose trimming in the ERQC is regulated by the competing activity of UGGT1, which reglucosylates N-glycans and opposes ERAD. The rate of trimming is also influenced by the availability and activity of EDEM proteins, which enhance mannose trimming and ERAD. In cancer cells, COPB2 facilitates EDEM3-mediated mannose trimming to sustain ER homeostasis, indicating that vesicular trafficking components can modulate this process. Additionally, the compartmentalization of ER mannosidase I within the ERQC contributes to regulation by concentrating enzyme and substrate.
endoplasmic reticulum mannose trimming and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| COPB2 | Ovarian cancer; ER homeostasis | COPB2 knockout or overexpression in ovarian cancer cell lines |
| EDEM3 | Cancer; ERAD regulation | EDEM3 knockout and point mutation models |
| UGGT1 | Protein folding disorders; ERAD competition | UGGT1 knockout and reglucosylation assays |
| MAN1B1 | Glycoprotein ERAD defects | MAN1B1 knockout in HEK293 or HeLa cells |
| EDEM1 | ERAD substrate delivery | EDEM1 knockout and tagged knock-in |
Cancer
COPB2 facilitates EDEM3-mediated mannose trimming to sustain ER homeostasis in ovarian cancer. This suggests that tumors can hijack the mannose trimming pathway to cope with ER stress and support survival. Dysregulation of GO:1904380 may therefore contribute to cancer progression and chemoresistance.
Protein conformational disorders
Mannose trimming is the dominant signal for the release of misfolded glycoproteins from ER quality control. When this process is impaired, misfolded proteins may accumulate, a hallmark of conformational diseases. UGGT1-mediated reglucosylation competes with ERAD, and an imbalance can exacerbate protein aggregation.
ER storage diseases and secretory defects
Because mannose trimming is required for delivery of glycoproteins from EDEM1 to XTP3-B and late ERAD steps, defects in this pathway can lead to ER storage and secretory abnormalities. ER mannosidase I is required for N-glycan trimming to Man5-6GlcNAc2 in glycoprotein ERAD, and its loss may cause accumulation of misfolded glycoproteins.
From endoplasmic reticulum mannose trimming-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ER mannosidase I block mannose trimming? | MAN1B1 knockout cell line |
| Does EDEM3 enhance mannose trimming and ERAD? | EDEM3 overexpression and knockout |
| Is mannose trimming required for EDEM1-to-XTP3-B delivery? | EDEM1 knockout with tagged XTP3-B knock-in |
| Does UGGT1 reglucosylation compete with ERAD? | UGGT1 point mutation and knockout |
| Does COPB2 facilitate EDEM3-mediated trimming in cancer? | COPB2 knockout in ovarian cancer cells |
| Is mannose trimming the dominant release signal? | Mannose trimming inhibitor treatment and glycan analysis |
How to Study the endoplasmic reticulum mannose trimming Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry of N-glycans | Mannose trimming intermediates (Man6-5GlcNAc2) | Quantify GO:1904380 products |
| Pulse-chase metabolic labeling | ERAD flux of glycoproteins | Test requirement for mannose trimming |
| Co-immunoprecipitation | Interaction between trimmed glycoproteins and lectins | Study EDEM1-to-XTP3-B delivery |
| Lectin blotting | Glycan structure recognition | Detect trimmed glycans |
| CRISPR knockout screening | Genes required for mannose trimming | Identify modifiers of ER homeostasis |
| RNA-seq | Transcriptional changes upon trimming inhibition | Analyze ER stress response |
| Fluorescent ERAD reporters | Real-time degradation kinetics | Live-cell imaging of ERAD |
| Site-directed mutagenesis | Catalytic activity of mannosidases | Test EDEM3 or MAN1B1 mutants |
Glycan analysis by mass spectrometry
Mass spectrometry of released N-glycans is used to quantify Man6-5GlcNAc2 intermediates generated by endoplasmic reticulum mannose trimming. This method directly measures the products of GO:1904380 and can be applied to cells with CRISPR-engineered mannosidase or EDEM mutations.
ERAD flux assays
ERAD flux is measured using pulse-chase metabolic labeling or fluorescent reporters that are degraded in a mannose-trimming-dependent manner. These assays test whether mannose trimming is required for delivery of substrates to late ERAD steps.
Lectin binding and co-immunoprecipitation
Co-immunoprecipitation and lectin binding assays detect interactions between trimmed glycoproteins and ERAD lectins such as XTP3-B and OS-9. These methods reveal how mannose trimming controls substrate handoff.
CRISPR screening and transcriptomics
CRISPR library screening combined with RNA-seq can identify genes that regulate mannose trimming and ER homeostasis. This approach is useful for discovering modifiers of GO:1904380 in cancer and other disease models.
How CRISPR Can Be Used to Study GO:1904380 endoplasmic reticulum mannose trimming
Knockout
CRISPR knockout of MAN1B1, EDEM1, EDEM2, EDEM3, or UGGT1 can abolish or alter endoplasmic reticulum mannose trimming, allowing researchers to test its role in ERAD and secretion. Knockout cell lines are essential for dissecting the contribution of each enzyme to GO:1904380.
Point Mutation
Point mutations in the catalytic domains of ER mannosidases or EDEM proteins can separate mannose trimming activity from substrate recognition. Such mutants help define the enzymatic mechanism of GO:1904380 and its regulation.
Knock-in
Knock-in of tagged alleles (e.g., HA- or GFP-tagged EDEM1 or XTP3-B) enables visualization and immunoprecipitation of mannose trimming complexes. Tagged knock-in models are valuable for tracking substrate delivery to late ERAD steps.
Overexpression
Overexpression of EDEM3 or other mannosidases enhances mannose trimming and ERAD, providing a gain-of-function system to study GO:1904380. Overexpression models are also used to test whether increased trimming protects against ER stress.
How EDITGENE Supports endoplasmic reticulum mannose trimming Research
Researchers studying endoplasmic reticulum mannose trimming-related genes often need to determine whether a candidate gene is causally involved in glycan processing, ERAD, or disease progression. EDITGENE provides CRISPR-based cell models and screening services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for endoplasmic reticulum mannose trimming research.
Frequently Asked Questions About endoplasmic reticulum mannose trimming
What is endoplasmic reticulum mannose trimming?
It is the biological process GO:1904380, defined as any protein alpha-1,2-demannosylation that takes place in the endoplasmic reticulum quality control compartment (ERQC).
What genes are involved in endoplasmic reticulum mannose trimming?
Key genes include MAN1B1, EDEM1, EDEM2, EDEM3, XTP3-B, OS-9, and UGGT1.
Why is mannose trimming important for ERAD?
Mannose trimming is the dominant signal for the release of misfolded glycoproteins from ER quality control and is required for delivery to late ERAD steps.
What is the role of EDEM3 in mannose trimming?
EDEM3 is a soluble EDEM homolog that enhances glycoprotein ERAD and mannose trimming.
How does UGGT1 compete with mannose trimming?
UGGT1-mediated reglucosylation of N-glycan competes with ER-associated degradation of unstable and misfolded glycoproteins.
What is the GO ID for endoplasmic reticulum mannose trimming?
The GO ID is GO:1904380.
Which enzymes catalyze mannose trimming in the ER?
ER mannosidase I and EDEM family proteins catalyze alpha-1,2-demannosylation in the ERQC.
What diseases are linked to mannose trimming defects?
Dysregulated mannose trimming has been linked to ovarian cancer through COPB2-facilitated EDEM3 activity.
How can I study endoplasmic reticulum mannose trimming in the lab?
Common methods include mass spectrometry of N-glycans, ERAD flux assays, co-immunoprecipitation, and CRISPR screening.
What CRISPR models are available for mannose trimming genes?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes such as MAN1B1, EDEM3, and UGGT1.
Conclusion
Endoplasmic reticulum mannose trimming (GO:1904380) is a decisive step in glycoprotein quality control that generates Man6-5GlcNAc2 signals for ERAD and regulates the folding-versus-degradation balance. Its core enzymes and lectins, including ER mannosidase I, EDEM1-3, XTP3-B, and UGGT1, are critical for ER homeostasis and are implicated in cancer and protein conformational disorders. CRISPR-based models and glycan profiling methods provide powerful tools to dissect this pathway and its disease relevance.
References
- 1. Okada T et al.. 2016. [Mannose trimming mechanism in endoplasmic reticulum-associated degradation of glycoproteins].. Seikagaku 88(2):257-60 PMID: 27192884
- 2. Frenkel Z et al.. 2003. Endoplasmic reticulum-associated degradation of mammalian glycoproteins involves sugar chain trimming to Man6-5GlcNAc2.. J Biol Chem 278(36):34119-24 PMID: 12829701
- 3. Groisman B et al.. 2011. Mannose trimming is required for delivery of a glycoprotein from EDEM1 to XTP3-B and to late endoplasmic reticulum-associated degradation steps.. J Biol Chem 286(2):1292-300 PMID: 21062743
- 4. Shin YJ et al.. 2025. Mannose trimming is the dominant signal for the release of misfolded glycoproteins from ER quality control.. J Biol Chem 301(10):110649 PMID: 40885387
- 5. Li DX et al.. 2025. COPB2 facilitates EDEM3-mediated mannose trimming to sustain ER homeostasis in ovarian cancer.. Cell Oncol (Dordr) 48(5):1465-1477 PMID: 40736660
- 6. Ninagawa S et al.. 2024. UGGT1-mediated reglucosylation of N-glycan competes with ER-associated degradation of unstable and misfolded glycoproteins.. Elife 12 PMID: 39654396
- 7. Avezov E et al.. 2008. Endoplasmic reticulum (ER) mannosidase I is compartmentalized and required for N-glycan trimming to Man5-6GlcNAc2 in glycoprotein ER-associated degradation.. Mol Biol Cell 19(1):216-25 PMID: 18003979
- 8. Hirao K et al.. 2006. EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming.. J Biol Chem 281(14):9650-8 PMID: 16431915
